A pan-cancer benchmark of integrated ferroptosis, cuproptosis and disulfidptosis prognostic signatures
Abdussamed Yasin Demir, Ekrem Yaşar
This paper benchmarks integrated cell-death prognostic signatures across cancers, finding they are biologically valid but not prognostically better than single-pathway models or proliferation markers.
bioRxiv · Jun 30, 2026 · PreprintBioinformatics